Speech Loudness and Quality 12 Months after Intensive Voice Treatment (LSVT®) for Parkinson’s Disease: A Comparison with an Alternative Speech Treatment

Publisher： Karger

E-ISSN： 1421-9972|54|6|296-303

ISSN： 1021-7762

Source： Folia Phoniatrica et Logopaedica, Vol.54, Iss.6, 2002-11, pp. : 296-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Short-Term Effects of Repetitive Transcranial Magnetic Stimulation on Speech and Voice in Individuals with Parkinson’s Disease

By  

Folia Phoniatrica et Logopaedica, Vol. 62, Iss. 3, 2010-04 ,pp. : 104-109

Karger

Access to resources Recommend Favorite

A Comparison of the Prosodic Characteristics of the Speech of People with Parkinson’s Disease and Friedreich’s Ataxia with Neurologically Normal Speakers

By  

Folia Phoniatrica et Logopaedica, Vol. 50, Iss. 1, 1998-02 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Lesioning the Subthalamic Nucleus in the Treatment of Parkinson’s Disease

By  

Stereotactic and Functional Neurosurgery, Vol. 77, Iss. 1-4, 2002-10 ,pp. : 68-72

Karger

Access to resources Recommend Favorite

Comparison of Atlas- and Magnetic-Resonance-Imaging-Based Stereotactic Targeting of the Subthalamic Nucleus in the Surgical Treatment of Parkinson’s Disease

By  

Stereotactic and Functional Neurosurgery, Vol. 86, Iss. 3, 2008-03 ,pp. : 153-161

Karger

Access to resources Recommend Favorite

Levodopa––carbidopa intestinal gel for treatment of advanced Parkinson’’s disease

By Fernandez H.H.   Odin P.  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 907-919

Informa Healthcare

Access to resources Recommend Favorite